ACS Medicinal Chemistry Letters最新文献

筛选
英文 中文
A Miniaturized Chemical High Throughput Experimentation Plate to Enable Late-Stage Oxidation Screening and Scale-up. 一个小型化的化学高通量实验板,使后期氧化筛选和放大。
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 eCollection Date: 2025-06-12 DOI: 10.1021/acsmedchemlett.5c00175
Javier Izquierdo-Ferrer, Mary E Bellizzi, Noah Tu, Andrew Bogdan, Ying Wang
{"title":"A Miniaturized Chemical High Throughput Experimentation Plate to Enable Late-Stage Oxidation Screening and Scale-up.","authors":"Javier Izquierdo-Ferrer, Mary E Bellizzi, Noah Tu, Andrew Bogdan, Ying Wang","doi":"10.1021/acsmedchemlett.5c00175","DOIUrl":"10.1021/acsmedchemlett.5c00175","url":null,"abstract":"<p><p>Chemical methods for Late-Stage Oxidation (LSO) of advanced and complex molecules remain a highly relevant topic, with new and improved methods being reported annually. Despite the growing number of methodologies, the scope and limitations of these methods in bioactive molecules is largely unknown. We have designed a High-Throughput Experimentation (HTE) plate based on validated LSO methods, capable of screening compounds using only a few milligrams, to enhance our Late-Stage Functionalization (LSF) platform. Various projects at AbbVie have benefited from this plate, generating essential data for programs and creating new analogs for comprehensive Structure-Activity Relationship (SAR) analysis. We demonstrated the transformative capabilities of this approach by screening nine well-known drugs and analyzed the oxidized derivatives. This report highlights how this overlooked transformation can be an effective synthetic tool for medicinal chemistry.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"916-924"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169457/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315504","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases 新型双环杂环作为MRGPRX2拮抗剂治疗炎性疾病
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 DOI: 10.1021/acsmedchemlett.5c0030510.1021/acsmedchemlett.5c00305
Ram W. Sabnis*, 
{"title":"Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases","authors":"Ram W. Sabnis*,&nbsp;","doi":"10.1021/acsmedchemlett.5c0030510.1021/acsmedchemlett.5c00305","DOIUrl":"https://doi.org/10.1021/acsmedchemlett.5c00305https://doi.org/10.1021/acsmedchemlett.5c00305","url":null,"abstract":"<p >Provided herein are novel bicyclic heterocycles as MRGPRX2 antagonists, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"980–981 980–981"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144260942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triazine Macrocycle Libraries: Synthesis, logD Prediction, and a Surprisingly Hydrophobic, Membrane-Permeable Diamine. 三嗪大环文库:合成,logD预测,和一个令人惊讶的疏水,膜透性二胺。
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 eCollection Date: 2025-06-12 DOI: 10.1021/acsmedchemlett.5c00078
Gretel A Stokes, Casey J Patterson-Gardner, Alexander M Engstrom, Alexander J Menke, K Harsha Vardhan Reddy, R Scott Lokey, Eric E Simanek
{"title":"Triazine Macrocycle Libraries: Synthesis, logD Prediction, and a Surprisingly Hydrophobic, Membrane-Permeable Diamine.","authors":"Gretel A Stokes, Casey J Patterson-Gardner, Alexander M Engstrom, Alexander J Menke, K Harsha Vardhan Reddy, R Scott Lokey, Eric E Simanek","doi":"10.1021/acsmedchemlett.5c00078","DOIUrl":"10.1021/acsmedchemlett.5c00078","url":null,"abstract":"<p><p>A library of triazine macrocycles was obtained to evaluate strategies for predicting lipophilicity using additive algorithms. Two synthetic routes were examined. While both were successful, one proved amenable to solution-phase library synthesis. The octanol-water partition coefficients (logP) were measured using reverse-phase HPLC at pH 10. When experimental and computed values (AlogP) are compared, a linear correlation is observed. That is, while additive algorithms underestimate hydrophobicity by a factor of 100, a simple correction yields accurate predictions. Two macrocycles showed anomalous hydrophobicities at high pH that were borne out in membrane transit (PAMPA) studies. Homodimers containing two primary amines were more hydrophobic than the corresponding heterodimers containing a single amine and a hydrophobic group. Structural analysis and computation provide a rationale for this behavior: the amines engage in an intramolecular hydrogen bond.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"1017-1023"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169478/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315469","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases. 新型双环杂环作为MRGPRX2拮抗剂治疗炎性疾病
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 eCollection Date: 2025-06-12 DOI: 10.1021/acsmedchemlett.5c00305
Ram W Sabnis
{"title":"Novel Bicyclic Heterocycles as MRGPRX2 Antagonists for Treating Inflammatory Diseases.","authors":"Ram W Sabnis","doi":"10.1021/acsmedchemlett.5c00305","DOIUrl":"10.1021/acsmedchemlett.5c00305","url":null,"abstract":"<p><p>Provided herein are novel bicyclic heterocycles as MRGPRX2 antagonists, pharmaceutical compositions, use of such compounds in treating inflammatory diseases, and processes for preparing such compounds.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"980-981"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169468/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Triazine Macrocycle Libraries: Synthesis, logD Prediction, and a Surprisingly Hydrophobic, Membrane-Permeable Diamine 三嗪大环文库:合成,logD预测,和一个令人惊讶的疏水,膜透性二胺
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 DOI: 10.1021/acsmedchemlett.5c0007810.1021/acsmedchemlett.5c00078
Gretel A. Stokes, Casey J. Patterson-Gardner, Alexander M. Engstrom, Alexander J. Menke, K. Harsha Vardhan Reddy, R. Scott Lokey and Eric E. Simanek*, 
{"title":"Triazine Macrocycle Libraries: Synthesis, logD Prediction, and a Surprisingly Hydrophobic, Membrane-Permeable Diamine","authors":"Gretel A. Stokes,&nbsp;Casey J. Patterson-Gardner,&nbsp;Alexander M. Engstrom,&nbsp;Alexander J. Menke,&nbsp;K. Harsha Vardhan Reddy,&nbsp;R. Scott Lokey and Eric E. Simanek*,&nbsp;","doi":"10.1021/acsmedchemlett.5c0007810.1021/acsmedchemlett.5c00078","DOIUrl":"https://doi.org/10.1021/acsmedchemlett.5c00078https://doi.org/10.1021/acsmedchemlett.5c00078","url":null,"abstract":"<p >A library of triazine macrocycles was obtained to evaluate strategies for predicting lipophilicity using additive algorithms. Two synthetic routes were examined. While both were successful, one proved amenable to solution-phase library synthesis. The octanol–water partition coefficients (logP) were measured using reverse-phase HPLC at pH 10. When experimental and computed values (AlogP) are compared, a linear correlation is observed. That is, while additive algorithms underestimate hydrophobicity by a factor of 100, a simple correction yields accurate predictions. Two macrocycles showed anomalous hydrophobicities at high pH that were borne out in membrane transit (PAMPA) studies. Homodimers containing two primary amines were more hydrophobic than the corresponding heterodimers containing a single amine and a hydrophobic group. Structural analysis and computation provide a rationale for this behavior: the amines engage in an intramolecular hydrogen bond.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"1017–1023 1017–1023"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144260870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Miniaturized Chemical High Throughput Experimentation Plate to Enable Late-Stage Oxidation Screening and Scale-up 一个小型化的化学高通量实验板,使后期氧化筛选和放大
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-06-02 DOI: 10.1021/acsmedchemlett.5c0017510.1021/acsmedchemlett.5c00175
Javier Izquierdo-Ferrer*, Mary E. Bellizzi, Noah Tu, Andrew Bogdan and Ying Wang, 
{"title":"A Miniaturized Chemical High Throughput Experimentation Plate to Enable Late-Stage Oxidation Screening and Scale-up","authors":"Javier Izquierdo-Ferrer*,&nbsp;Mary E. Bellizzi,&nbsp;Noah Tu,&nbsp;Andrew Bogdan and Ying Wang,&nbsp;","doi":"10.1021/acsmedchemlett.5c0017510.1021/acsmedchemlett.5c00175","DOIUrl":"https://doi.org/10.1021/acsmedchemlett.5c00175https://doi.org/10.1021/acsmedchemlett.5c00175","url":null,"abstract":"<p >Chemical methods for Late-Stage Oxidation (LSO) of advanced and complex molecules remain a highly relevant topic, with new and improved methods being reported annually. Despite the growing number of methodologies, the scope and limitations of these methods in bioactive molecules is largely unknown. We have designed a High-Throughput Experimentation (HTE) plate based on validated LSO methods, capable of screening compounds using only a few milligrams, to enhance our Late-Stage Functionalization (LSF) platform. Various projects at AbbVie have benefited from this plate, generating essential data for programs and creating new analogs for comprehensive Structure–Activity Relationship (SAR) analysis. We demonstrated the transformative capabilities of this approach by screening nine well-known drugs and analyzed the oxidized derivatives. This report highlights how this overlooked transformation can be an effective synthetic tool for medicinal chemistry.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"916–924 916–924"},"PeriodicalIF":3.5,"publicationDate":"2025-06-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144261079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating Cancers 新型2,6,9-三取代嘌呤作为CDK2抑制剂治疗癌症
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-05-30 DOI: 10.1021/acsmedchemlett.5c0028210.1021/acsmedchemlett.5c00282
Jian Rong,  and , Steven H. Liang*, 
{"title":"Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating Cancers","authors":"Jian Rong,&nbsp; and ,&nbsp;Steven H. Liang*,&nbsp;","doi":"10.1021/acsmedchemlett.5c0028210.1021/acsmedchemlett.5c00282","DOIUrl":"https://doi.org/10.1021/acsmedchemlett.5c00282https://doi.org/10.1021/acsmedchemlett.5c00282","url":null,"abstract":"<p >This highlight describes novel 2,6,9-trisubstituted purines as cyclin-dependent kinase 2 (CDK2) inhibitors. It details the novel 2,6,9-trisubstituted purine compounds, the pharmaceutical composition, use, and treatment for CDK2-related diseases, such as cancers.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"970–971 970–971"},"PeriodicalIF":3.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144261170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating Cancers. 新型2,6,9-三取代嘌呤作为CDK2抑制剂治疗癌症
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-05-30 eCollection Date: 2025-06-12 DOI: 10.1021/acsmedchemlett.5c00282
Jian Rong, Steven H Liang
{"title":"Novel 2,6,9-Trisubstituted Purines as CDK2 Inhibitors for Treating Cancers.","authors":"Jian Rong, Steven H Liang","doi":"10.1021/acsmedchemlett.5c00282","DOIUrl":"10.1021/acsmedchemlett.5c00282","url":null,"abstract":"<p><p>This highlight describes novel 2,6,9-trisubstituted purines as cyclin-dependent kinase 2 (CDK2) inhibitors. It details the novel 2,6,9-trisubstituted purine compounds, the pharmaceutical composition, use, and treatment for CDK2-related diseases, such as cancers.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"970-971"},"PeriodicalIF":3.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169447/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders. 新型吲哚衍生物作为5 -羟色胺能致幻剂用于治疗精神病、精神疾病和中枢神经系统障碍。
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-05-30 eCollection Date: 2025-06-12 DOI: 10.1021/acsmedchemlett.5c00309
Ram W Sabnis
{"title":"Novel Indole Derivatives as Serotonergic Psychedelic Agents for Treating Psychosis, Mental Illness, and CNS Disorders.","authors":"Ram W Sabnis","doi":"10.1021/acsmedchemlett.5c00309","DOIUrl":"10.1021/acsmedchemlett.5c00309","url":null,"abstract":"<p><p>Provided herein are novel indole derivatives as serotonergic psychedelic agents, pharmaceutical compositions, use of such compounds in treating psychosis, mental illness and central nervous system (CNS) disorders, and processes for preparing such compounds.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"982-983"},"PeriodicalIF":3.5,"publicationDate":"2025-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12169492/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144315531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) Antagonists 新型精氨酸抗利尿激素受体1A (AVPR1A)拮抗剂的合成与应用
IF 3.5 3区 医学
ACS Medicinal Chemistry Letters Pub Date : 2025-05-29 DOI: 10.1021/acsmedchemlett.5c0028510.1021/acsmedchemlett.5c00285
Xin Zhou,  and , Steven H. Liang*, 
{"title":"Synthesis and Application of Novel Arginine Vasopressin Receptor 1A (AVPR1A) Antagonists","authors":"Xin Zhou,&nbsp; and ,&nbsp;Steven H. Liang*,&nbsp;","doi":"10.1021/acsmedchemlett.5c0028510.1021/acsmedchemlett.5c00285","DOIUrl":"https://doi.org/10.1021/acsmedchemlett.5c00285https://doi.org/10.1021/acsmedchemlett.5c00285","url":null,"abstract":"<p >Arginine Vasopressin Receptor 1A (AVPR1A) is a member of G-protein-coupled receptors (GPCRs) that binds arginine vasopressin (AVP) and is primarily related to cardiovascular function, glycogenolysis, and social behaviors. This patent describes the synthesis of a series of AVPR1A antagonists and their applications in related disease treatment.</p>","PeriodicalId":20,"journal":{"name":"ACS Medicinal Chemistry Letters","volume":"16 6","pages":"963–964 963–964"},"PeriodicalIF":3.5,"publicationDate":"2025-05-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144260990","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信